52 / 100

Dr. Carlos Prudencio, Serology, Research Advancement Paper Award

Doctorate at Instituto Adolfo Lutz, Brazil


Dr. Carlos Prudencio is a leading researcher in the field of molecular biology and immunology, currently serving at the Immunology Center of the Adolfo Lutz Institute in São Paulo. With a robust academic background, including a PhD in Genetics from the Federal University of Uberlândia and postdoctoral research in Biotechnology and Preventive Veterinary Medicine, Dr. Prudencio has made significant contributions to the scientific community. His expertise in phage display and the development of diagnostic tools and vaccines has been instrumental in advancing public health initiatives. Dr. Prudencio continues to drive innovative research, particularly in understanding and combating viral pathogens, with numerous projects funded by top research agencies.

Professional Profile:


PhD in Genetics

  • Institution: Federal University of Uberlândia, Uberlândia, MG, Brazil
  • Year: 2008

Master’s in Genetics

  • Institution: Federal University of Uberlândia, Uberlândia, MG, Brazil
  • Year: 2008

Graduated in Veterinary Medicine

  • Institution: Federal University of Uberlândia, Uberlândia, MG, Brazil
  • Year: 2002

Post-Doctorate in Biotechnology

  • Institution: Instituto de Investigación en Recursos Cinegéticos, Universidad de Castilla-La Mancha, Ciudad Real, Castilla, Spain
  • Year: 2009

Post-Doctorate in Preventive Veterinary Medicine and Animal Health

  • Institution: Faculty of Veterinary Medicine and Animal Science, University of São Paulo, São Paulo, Brazil
  • Year: 2012

Professional Experience:

Dr. Carlos Prudencio is a distinguished scientific researcher with extensive experience in molecular biology, immunology, phage display, and the development of diagnostic biomarkers and vaccines. Since 2012, he has been a key researcher at the Immunology Center of the Adolfo Lutz Institute in São Paulo, where he also heads the Immunotech laboratory. In his role, Dr. Prudencio has led numerous high-impact research projects, including those funded by prominent organizations such as the Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) and the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq). His work has significantly contributed to the understanding of humoral immune responses and the development of vaccines against various pathogens, including the Zika virus and SARS-CoV-2.

Research Interest:

Dr. Prudencio’s research interests encompass molecular biology, immunology, and biotechnology, with a focus on the following areas:

Phage display technology for screening and identifying monoclonal antibodies.

Development of diagnostic biomarkers and vaccines.

Humoral immune response profiling for pathogens of public health interest.

Innovative approaches to vaccine development, particularly against emerging viral diseases.

Publications Top Noted: 

Experimental studies using OMV in a new platform of SARS-CoV-2 vaccines

  • Gaspar, E.B., Prudencio, C.R., & De Gaspari, E.
  • Human Vaccines & Immunotherapeutics, 17(9), 2965-2968, 2021
  • Citation Count: 30

Peptide mimicking antigenic and immunogenic epitope of neuwiedase from Bothrops neuwiedi snake venom

  • Cardoso, R., Homsi-Brandeburgo, M.I., Rodrigues, V.M., Santos, W.B., & Prudencio, C.R.
  • Toxicon, 53(2), 254-261, 2009
  • Citation Count: 28

Zika virus serological diagnosis: commercial tests and monoclonal antibodies as tools

  • Silva, I.B.B., Silva, A.S., Cunha, M.S., Cabral, A.D., Oliveira, K.C.A., Gaspari, E.D., & Prudencio, C.R.
  • Journal of Venomous Animals and Toxins including Tropical Diseases, 26, e20200019, 2020
  • Citation Count: 16

Different drug approaches to COVID-19 treatment worldwide: an update of new drugs and drugs repositioning to fight against the novel coronavirus

  • Oliver, J.C., Silva, E.N., Soares, L.M., Scodeler, G.C., Santos, A.S., Corsetti, P.P., & Prudencio, C.R.
  • Therapeutic Advances in Vaccines and Immunotherapy, 10, 25151355221144845, 2022
  • Citation Count: 10

Systematic surveillance and meta-analysis of antimicrobial resistance and food sources from China and the USA

  • Himanshu, Prudencio, C.R., Costa, A.C., Leal, E., Chang, C.M., & Pandey, R.P.
  • Antibiotics, 11(11), 1471, 2022
  • Citation Count: 10
Carlos Prudencio | Serology | Research Advancement Paper Award

You May Also Like